How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.The concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group have daily limit, while the concept of humanoid robot is active again and again. Wuzhou New Year, Hanyu Group, Astar, Fenda Technology have daily limit, and Keli Sensing and Tianyue Mathematics have followed up.AMD Lisa Su was named CEO of the Year by Time magazine, and Time magazine published a blog post yesterday (December 10th) to select lisa su, CEO of AMD, as "CEO of 2024". The blog post tells the story of how lisa su led the company to turn losses into profits and challenged the giant NVIDIA in the field of artificial intelligence chips.
Haoen Automobile & Power Co., Ltd. established a laser technology company with a registered capital of 50 million yuan. According to the enterprise search APP, Shenzhen Haoen Laser Technology Co., Ltd. was established recently, with Chen Tefang as the legal representative and a registered capital of 50 million yuan. Its business scope includes research and development of auto parts. Software development; Internet of things technology research and development; Internet of things technical services; Digital technology services; Intelligent vehicle equipment manufacturing; Radar and supporting equipment manufacturing, etc. Enterprise equity penetration shows that the company is wholly owned by Haoen Automobile and Power Company.JPMorgan Chase: The momentum of Xiaomi's electric vehicle will continue to be rated as "overweight". According to a research report published by JPMorgan Chase, Xiaomi Group announced that it will launch the second electric vehicle named Xiaomi Yuqi in the middle of next year, which is an SUV model. The product portfolio of electric vehicle business continues to expand, reflecting that the Group's ability to enter the electric vehicle market is better than market expectations. The delivery target of Xiaomi SU7, the first electric vehicle, has also been raised twice, and the gross profit margin of electric vehicle business has reached a medium-high level in the first two quarters, far exceeding the initial market expectation and only recorded a slight gross profit margin. Motong said that at present, we are waiting for the Group to announce more details about the new car's life, pricing and battery. We believe that the strong sales momentum of SU7, the profitability of the Group's core business and electric vehicle business, and the expectation that new models will be launched in the second half of next year will continue to promote the stock price in the next 6 to 12 months. The positive catalysts in the future include more details or pricing of YU7, further expansion of electric vehicle production capacity, exceeding expectations in core business performance, and large-scale and national consumption stimulus measures introduced by the country in the future.Hong Kong stocks fell, while the Hang Seng Index and Hang Seng Technology Index both fell.
Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.SDIC Power and others have invested in the establishment of a new energy development company. The enterprise search APP shows that recently, Ganzi Yalongjiang Energy Development Co., Ltd. was established with Zhang Peng as its legal representative and a registered capital of 500 million yuan. Its business scope includes: solar power generation technical services; Research and development of emerging energy technologies; Technical services for wind power generation; Energy storage technology services, etc. Enterprise equity penetration shows that the company is jointly owned by Yalong River Basin Hydropower Development Co., Ltd. and Ganzi Energy Development Group Co., Ltd., a subsidiary of SDIC Power.Yonhap News Agency: South Korean Prime Minister Han Dezhu blamed himself for failing to stop martial law.